Skip to content
Medical Health Aged Care

The Personalized Lifestyle Medicine Institute Announces the 11th Annual Thought Leaders Consortium

Personalized Lifestyle Medicine Institute 3 mins read

SEATTLE, WA / ACCESSWIRE / August 22, 2023 / The Personalized Lifestyle Medicine Institute (PLMI) is excited to bring together researchers, clinicians, industry leaders, and anyone interested in Functional Medicine for its 11th Annual Thought Leaders Consortium: Next Generation Clinical Management of Chronic Neuroimmune Disorders this October in Seattle, WA.

Personalized Lifestyle Medicine Institute
Personalized Lifestyle Medicine Institute
11th Annual Thought Leaders Consortium


The two-day event, located at the Seattle Marriott Waterfront, features leading innovators in the application of next-generation approaches for managing complex chronic neuroimmune disorders and will focus on recent discoveries and how to translate this information into clinical practice.

The program will explore the root causes of illness, the complexity of genetic and epigenetic influences, and the power of lifestyle, diet, and environmental and social factors that can impact therapeutic outcomes, with an emphasis on skill development, faculty interaction, and dynamic attendee participation.

With more than 35 countries represented, this immersive educational event is a realization of PLMI's mission to bring together researchers, clinicians, industry leaders, media leaders, and other stakeholders to focus on new models of healthcare delivery, advancements in medical nutrition therapy, and exciting emerging science.

Beginning on October 20, the first session focuses on advances in the management of neuroimmune disorders, with speakers including Jeffrey Bland, Ph.D., who has spent more than four decades focused on the improvement of human health and is known worldwide as the founder of the Functional Medicine movement. His pioneering work created PLMI as well as the Institute for Functional Medicine (IFM). Other topics will include the unique features of specific plant foods in managing neuroimmune disorders and genomic testing and what it says about the risk of neuroimmune disorders.

Three more engaging sessions will be covered during the event with topics including neuroimmune assessment and intervention, advances in personalizing neuroimmune interventions, and advances in repairing broken brain-behavior connections. Attendees will hear from internationally recognized experts such as Dr. Terry Wahls, Aristo Vojdani, PhD, MD, Bridget Briggs, MD, Deanna Minich, Ph.D., CNS, Dale Bredesen, MD, and more. For a full list of speakers and their topics, see the event agenda here.

The last session will also include a discussion period among faculty and attendees and end with closing comments from Dr. Bland.

PLMI looks forward to exploring these approaches to managing chronic conditions with the consortium's attendees. Space is limited at the event, and those wishing to attend can register here.

About PLMI:

The mission of the Personalized Lifestyle Medicine Institute is to bring together researchers, clinicians, industry leaders, media leaders, and other stakeholders to focus on new models of healthcare delivery, advancements in medical nutrition therapy, and exciting emerging science. Our vision encompasses building a community around dynamic collaborations, compelling dialogues, evidence-based information and resources, and immersive educational events. Since 1991, hundreds of thousands of healthcare practitioners have participated in PLMI programs, and this collective knowledge has positively impacted the lives of patients all over the world.

Contact Information

Nicole Fox
Media Management
[email protected]
(206) 201-3794

SOURCE: Personalized Lifestyle Medicine Institute (PLMI)

.


View source version on accesswire.com:
https://www.accesswire.com/775526/The-Personalized-Lifestyle-Medicine-Institute-Announces-the-11th-Annual-Thought-Leaders-Consortium

More from this category

  • General News, Medical Health Aged Care
  • 12/03/2026
  • 14:07
Parliament of Australia

Public hearing concerning the National Redress Scheme

TheJoint Standing Committee on Implementation of the National Redress Schemewill hold a public hearing in Canberra on Friday, 13 March 2026, for itsinquiry into the continuing operation of the Scheme. Committee Chair, Ms Jodie Belyea MP, said the Committee is grateful for the contributions made in support of the inquiry to date. ‘The National Redress Scheme plays a central role in Australia’s response to institutional child sexual abuse. It is an important program for a significant number of people. The Committee has received a substantial number of submissions in support of our current inquiry, and public hearings over the coming…

  • Energy, Medical Health Aged Care
  • 12/03/2026
  • 12:11
Sweltering Cities

The cost of keeping cool is making Australians sick: New report reveals millions forced to ration cooling during record heat

12 March 2026 Sweltering Cities has today released the findings of its 2026 Summer Survey, exposing a national health crisis driven by the rising cost of keeping cool. With data from more than 2,600 respondents across 766 postcodes, the report proves that for many Australians the high cost of staying cool is having serious physical and mental health impacts. The 2025/26 summer saw 68% of all respondents report feeling unwell due to heat. However, the survey reveals that this burden is falling most heavily on those already struggling with the cost of living. For renters and people with disabilities, the…

  • Medical Health Aged Care
  • 12/03/2026
  • 10:01
Monash University

Monash Researchers Awarded up to $22.4 Million AUD to Develop New Medicines for Restoring Lymphatic Pumping

Monash University is partnering with the University of Missouri and the University of Pennsylvania to develop first-in-class medicines designed to reverse poor lymphatic vessel contraction and transport function, backed by an up to $22.4 million AUD Award from the Advanced Research Projects Agency for Health (ARPA-H). The researchers join ARPA-H’s GLIDE (Groundbreaking Lymphatic Interventions and Drug Exploration) program to transform how both primary lymphatic diseases and common chronic diseases are treated by developing innovative therapeutics that alleviate, repair or regenerate a dysfunctional lymphatic vascular system. Professor Arthur Christopoulos, Dean of the Faculty of Pharmacy and Pharmaceutical Sciences, said the work…

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.